Aurora Cannabis 4Q Loss Widens on Higher Costs

Dow Jones06-11

By Adriano Marchese

Aurora Cannabis' logged a wider loss in its fourth quarter as higher costs offset a rise in revenue.

For the three months ended March 31, the Canadian medical cannabis company posted a net loss from continuing operations of 27.6 million Canadian dollars ($19.8 million), compared with a loss of C$12.1 million in the comparable quarter a year ago.

Aurora said the widened loss was primarily related to other expenses of C$1.7 million in the current period, compared to other income of C$11.9 million in the prior year period.

On an adjusted basis, which strips out exceptional items and one-off costs, earnings fell to a profit C$5.6 million from C$15.3 million.

Total revenue rose to C$84.8 million from C$76.8 million, and came in ahead of expectations which anticipated a slight decline to C$75.7 million.

Aurora said that growth over the prior year was mainly due to a 14% growth in the global medical cannabis business as well as higher wholesale bulk cannabis net revenue.

Meanwhile, consumer cannabis was softer in the period, declining by more than half from the year-prior.

Write to Adriano Marchese at adriano.marchese@wsj.com

(END) Dow Jones Newswires

June 11, 2026 08:08 ET (12:08 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2642928120?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-11 20:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2642928120","market":"sh","top_or_hot":-1,"title":"Aurora Cannabis 4Q Loss Widens on Higher Costs","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Adriano Marchese \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/ACB\">Aurora Cannabis</a>' logged a wider loss in its fourth quarter as higher costs offset a rise in revenue. \n</p>\n<p>\n  For the three months ended March 31, the Canadian medical cannabis company posted a net loss from continuing operations of 27.6 million Canadian dollars ($19.8 million), compared with a loss of C$12.1 million in the comparable quarter a year ago. \n</p>\n<p>\n  Aurora said the widened loss was primarily related to other expenses of C$1.7 million in the current period, compared to other income of C$11.9 million in the prior year period. \n</p>\n<p>\n  On an adjusted basis, which strips out exceptional items and one-off costs, earnings fell to a profit C$5.6 million from C$15.3 million. \n</p>\n<p>\n  Total revenue rose to C$84.8 million from C$76.8 million, and came in ahead of expectations which anticipated a slight decline to C$75.7 million. \n</p>\n<p>\n  Aurora said that growth over the prior year was mainly due to a 14% growth in the global medical cannabis business as well as higher wholesale bulk cannabis net revenue. \n</p>\n<p>\n  Meanwhile, consumer cannabis was softer in the period, declining by more than half from the year-prior. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Adriano Marchese at adriano.marchese@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 11, 2026 08:08 ET (12:08 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Aurora Cannabis 4Q Loss Widens on Higher Costs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAurora Cannabis 4Q Loss Widens on Higher Costs\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-06-11 20:08</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Adriano Marchese \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/ACB\">Aurora Cannabis</a>' logged a wider loss in its fourth quarter as higher costs offset a rise in revenue. \n</p>\n<p>\n  For the three months ended March 31, the Canadian medical cannabis company posted a net loss from continuing operations of 27.6 million Canadian dollars ($19.8 million), compared with a loss of C$12.1 million in the comparable quarter a year ago. \n</p>\n<p>\n  Aurora said the widened loss was primarily related to other expenses of C$1.7 million in the current period, compared to other income of C$11.9 million in the prior year period. \n</p>\n<p>\n  On an adjusted basis, which strips out exceptional items and one-off costs, earnings fell to a profit C$5.6 million from C$15.3 million. \n</p>\n<p>\n  Total revenue rose to C$84.8 million from C$76.8 million, and came in ahead of expectations which anticipated a slight decline to C$75.7 million. \n</p>\n<p>\n  Aurora said that growth over the prior year was mainly due to a 14% growth in the global medical cannabis business as well as higher wholesale bulk cannabis net revenue. \n</p>\n<p>\n  Meanwhile, consumer cannabis was softer in the period, declining by more than half from the year-prior. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Adriano Marchese at adriano.marchese@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 11, 2026 08:08 ET (12:08 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MJ","symbol_name":"Amplify Alternative Harvest ETF","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2642928120","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2642928120","pubTimestamp":1781179680,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Aurora Cannabis' logged a wider loss in its fourth quarter as higher costs offset a rise in revenue.For the three months ended March 31, the Canadian medical cannabis company posted a net loss from continuing operations of 27.6 million Canadian dollars , compared with a loss of C$12.1 million in the comparable quarter a year ago.Aurora said the widened loss was primarily related to other expenses of C$1.7 million in the current period, compared to other income of C$11.9 million in the prior year period.On an adjusted basis, which strips out exceptional items and one-off costs, earnings fell to a profit C$5.6 million from C$15.3 million.Total revenue rose to C$84.8 million from C$76.8 million, and came in ahead of expectations which anticipated a slight decline to C$75.7 million.Aurora said that growth over the prior year was mainly due to a 14% growth in the global medical cannabis business as well as higher wholesale bulk cannabis net revenue.Meanwhile, consumer cannabis was softer in","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MJ":"Amplify Alternative Harvest ETF","BK4007":"制药","TOKE":"Cambria Cannabis ETF","MSOS":"AdvisorShares Pure US Cannabis ETF","CNBS":"Amplify Seymour Cannabis ETF","MSOX":"AdvisorShares MSOX 2X Daily ETF","YOLO":"AdvisorShares Pure Cannabis ETF","BK4557":"大麻股","ACB":"奥罗拉大麻公司","WEED":"Roundhill Cannabis ETF"},"translate_title":"Aurora Cannabis第四季度亏损因成本上升而扩大","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TOKE":1.5,"MSOS":1.5,"WEED":1.5,"YOLO":1.5,"MJ":1.5,"ACB":1.5,"CNBS":1.5,"MSOX":1.5},"content_text":"By Adriano Marchese \n\n\n \n\n\nAurora Cannabis' logged a wider loss in its fourth quarter as higher costs offset a rise in revenue. \n\n\n  For the three months ended March 31, the Canadian medical cannabis company posted a net loss from continuing operations of 27.6 million Canadian dollars ($19.8 million), compared with a loss of C$12.1 million in the comparable quarter a year ago. \n\n\n  Aurora said the widened loss was primarily related to other expenses of C$1.7 million in the current period, compared to other income of C$11.9 million in the prior year period. \n\n\n  On an adjusted basis, which strips out exceptional items and one-off costs, earnings fell to a profit C$5.6 million from C$15.3 million. \n\n\n  Total revenue rose to C$84.8 million from C$76.8 million, and came in ahead of expectations which anticipated a slight decline to C$75.7 million. \n\n\n  Aurora said that growth over the prior year was mainly due to a 14% growth in the global medical cannabis business as well as higher wholesale bulk cannabis net revenue. \n\n\n  Meanwhile, consumer cannabis was softer in the period, declining by more than half from the year-prior. \n\n\n \n\n\n  Write to Adriano Marchese at adriano.marchese@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 11, 2026 08:08 ET (12:08 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2642928120","isCrawlerRequest":true}